Cargando…

Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders

The combination of statins and fibrates in the treatment of lipid abnormalities effectively regulates individual lipid fraction levels. In this study, the screening and assessment of the physicochemical properties of simvastatin-fenofibrate solid dispersions were performed. Fenofibrate and simvastat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Górniak, Agata, Czapor-Irzabek, Hanna, Złocińska, Adrianna, Gawin-Mikołajewicz, Agnieszka, Karolewicz, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962408/ https://www.ncbi.nlm.nih.gov/pubmed/36839925 http://dx.doi.org/10.3390/pharmaceutics15020603

Ejemplares similares

Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations
por: Górniak, Agata, et al.
Publicado: (2022)

Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control
por: Gawin-Mikołajewicz, Agnieszka, et al.
Publicado: (2021)

The Potential Antimicrobial Action of Human Mucin 7 15-Mer Peptide and Its Metal Complexes
por: Janicka-Kłos, Anna, et al.
Publicado: (2021)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
por: Tarantino, Nicola, et al.
Publicado: (2017)

Oral Wound Healing Potential of Polygoni Cuspidati Rhizoma et Radix Decoction—In Vitro Study
por: Hadzik, Jakub, et al.
Publicado: (2023)

Physicochemical and Antifungal Properties of Clotrimazole in Combination with High-Molecular Weight Chitosan as a Multifunctional Excipient
por: Grimling, Bożena, et al.
Publicado: (2020)

Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
por: Reyes-Soffer, Gissette, et al.
Publicado: (2013)

Hierarchical Macro-Mesoporous Silica Monolithic Tablets as a Novel Dose–Structure-Dependent Delivery System for the Release of Confined Dexketoprofen
por: Kozakiewicz-Latała, Marta, et al.
Publicado: (2022)

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
por: Karolewicz, Bożena, et al.
Publicado: (2019)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Formulation and Solid State Characterization of Nicotinamide-based Co-crystals of Fenofibrate
por: Shewale, Sheetal, et al.
Publicado: (2015)

Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions
por: Nowak, Maciej, et al.
Publicado: (2019)

Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation
por: Padhye, S. G., et al.
Publicado: (2013)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
por: Kazemi, Moloud, et al.
Publicado: (2018)

The Effect of PEG Molecular Weights on Dissolution Behavior of Simvastatin in Solid Dispersions
por: Bolourchian, Noushin, et al.
Publicado: (2013)

Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tablets
por: Pabari, Ritesh M, et al.
Publicado: (2014)

Parameters of Oxidative and Inflammatory Status in a Three-Month Observation of Patients with Acute Myocardial Infarction Undergoing Coronary Angioplasty—A Preliminary Study
por: Żurawska-Płaksej, Ewa, et al.
Publicado: (2019)

Ternary Eutectic Ezetimibe–Simvastatin–Fenofibrate System and the Physical Stability of Its Amorphous Form
por: Knapik-Kowalczuk, Justyna, et al.
Publicado: (2021)

Production and characterization of lipopeptide biosurfactant from a new strain of Pseudomonas antarctica 28E using crude glycerol as a carbon source
por: Ciurko, Dominika, et al.
Publicado: (2023)

Evaluation of the Influence of a Hydrogel Containing AMPD on the Stability of Tetracycline Hydrochloride
por: Kostrzębska, Agnieszka, et al.
Publicado: (2021)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Role of Alternative Lipid Excipients in the Design of Self-Nanoemulsifying Formulations for Fenofibrate: Characterization, in vitro Dispersion, Digestion and ex vivo Gut Permeation Studies
por: Alshamsan, Aws, et al.
Publicado: (2018)

Pectin and Neutral Monosaccharides Production during the Simultaneous Hydrothermal Extraction of Waste Biomass from Refining of Sugar—Optimization with the Use of Doehlert Design
por: Pińkowska, Hanna, et al.
Publicado: (2019)

The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats
por: Vukšić, Antonija, et al.
Publicado: (2023)

Optimizing the Formulation for Ginkgolide B Solid Dispersion
por: Wu, Xiao, et al.
Publicado: (2018)

Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of Curcumin
por: Song, Jae Geun, et al.
Publicado: (2022)

Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021)

Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects
por: Li, Guofei, et al.
Publicado: (2018)

Poloxamer 407-Based Thermosensitive Emulgel as a Novel Formulation Providing a Controlled Release of Oil-Soluble Pharmaceuticals—Ibuprofen Case Study
por: Grela, Kamil P., et al.
Publicado: (2021)

Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion
por: Binte Abu Bakar, Syaza Y., et al.
Publicado: (2019)

Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2015)

Formulation and Evaluation of Extended-Release Solid Dispersion of Metformin Hydrochloride
por: Patil, SA, et al.
Publicado: (2010)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
por: Eisa, Aya M., et al.
Publicado: (2022)

Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
por: Dharani, Sathish, et al.
Publicado: (2022)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
por: Farnier, Michel, et al.
Publicado: (2011)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Comparison of Efficacy and Safety of Fixed Dose Combination of Rosuvastatin and Choline Fenofibrate to Fixed Dose Combination of Rosuvastatin and Fenofibrate in Patients of Mixed Dyslipidemia: A Randomized, Open-label, Multicentre Clinical Trial in Indian Population
por: Barkate, Hanmant, et al.
Publicado: (2018)

The Influence of Fed State Lipolysis Inhibition on the Intraluminal Behaviour and Absorption of Fenofibrate from a Lipid-Based Formulation
por: Braeckmans, Marlies, et al.
Publicado: (2022)

Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
por: Koh, P. T., et al.
Publicado: (2013)

Solid Dispersion Formulations by FDM 3D Printing—A Review
por: Khalid, Garba M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_62gbr8u9knavdui38r92cac9gc